Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 7 (PPIAP7) is a human pseudogene located in the genome and designated by the symbol PPIAP7 or alias PPIP7[2][4][6]. As a pseudogene, it is a copied DNA segment resembling the gene for peptidylprolyl isomerase A (PPIA), but it is considered non-coding and does not produce a functional protein. Pseudogenes like PPIAP7 typically arise from gene duplication or retrotransposition events and have lost their ability to encode active proteins due to mutations or truncations[2][4][6]. There is currently no evidence that PPIAP7 functions as a gene product or is druggable, nor is it directly associated with disease in the way active, protein-coding genes are. Mutations or expression changes in other members of the peptidylprolyl isomerase A family, such as the functional PPIA gene (encoding cyclophilin A), have been studied in disease contexts, but those roles do not pertain to PPIAP7[1][5]. Some pseudogenes have been found to regulate gene expression indirectly, but specific regulatory functions for PPIAP7 have not been reported in the available literature or databases[2][4][6]. Clarification: You may encounter related pseudogenes such as PPIAP22, which have been studied for their potential role as competing endogenous RNAs affecting the regulation of functional PPIA and implicated in cancer[5]. However, there are currently no publications or database entries indicating that PPIAP7 shares such functions. If you have a specific interest in the peptidylprolyl isomerase A family’s biological functions, disease roles, or drug relevance, refer to the protein-coding gene Peptidylprolyl isomerase A (PPIA, Cyclophilin A) instead, not this pseudogene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 7 (PPIAP7).